SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-025335
Filing Date
2023-02-24
Accepted
2023-02-24 16:32:18
Documents
1
Period of Report
2023-02-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm237745-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm237745-3_4seq1.xml 4 4181
  Complete submission text file 0001104659-23-025335.txt   5653
Mailing Address C/O DIPEXIUM PHARMACEUTICALS, LLC 74 BROAD STREET NEW YORK NY 10004
Business Address
Shawah Robert G. (Reporting) CIK: 0001601121 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40536 | Film No.: 23667931

Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Issuer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations